Researchers have managed to modify a class of proteins to give them the ability to transport and store electricity. These ...

At the booth of Gilead Sciences, Lenacapavir, to be used as the world's only twice-yearly, long-acting injectable for HIV ...

The startup claims its medicines may be able to overcome the limitations of conventional antibody-drug conjugates by ...

Discover the simple, two-ingredient snack that registered dietitians recommend for boosting cognitive function and promoting ...

If nutrition is a popularity contest, one macro has emerged victorious. Driven by cultural pressure and disseminated via the internet, protein hysteria has reached a fever pitch. Per The Economist, ...

MPA on track to become the first NAM approved by the FDA for specificity testing PHILADELPHIA, /PRNewswire/ -- Integral Molecular, a leader in antibody discovery and characterization, announces that ...

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. We recently developed a high-throughput peptide array ...

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Droplet microarrays on ...

Off-target binding can be a significant hurdle in the development of antibody-based therapies, contributing to unexpected side effects in patients, reduced drug efficacy, and regulatory challenges.